Ticker
KROSCompany Name
KEROS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Inventory | Current Liabilities | Quick Ratio |
---|---|---|---|---|
6/30/2025 | $ 732.81M | $ 0 | $ 34.71M | 21.11 |
3/31/2025 | $ 759.51M | $ 0 | $ 39.38M | 19.29 |
12/31/2024 | $ 588.89M | $ 0 | $ 27.45M | 21.45 |
9/30/2024 | $ 552.05M | $ 0 | $ 29.01M | 19.03 |
6/30/2024 | $ 432.71M | $ 0 | $ 21.25M | 20.37 |
3/31/2024 | $ 463.13M | $ 0 | $ 18.72M | 24.74 |
12/31/2023 | $ 347.29M | $ 0 | $ 24.37M | 14.25 |
9/30/2023 | $ 304.44M | $ 0 | $ 16.7M | 18.23 |
6/30/2023 | $ 334.31M | $ 0 | $ 16.09M | 20.77 |
3/31/2023 | $ 362.22M | $ 0 | $ 15.46M | 23.43 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(AssetsC - Inventory) / LiabilitesC
(=) Quick Ratio
Quick Ratio for KEROS THERAPEUTICS INC is calculated as follows: (AssetsC [ $ 136.42M ] - Inventory [ $ 0 ]) / LiabilitesC [ $ 6.83M ]
(=) Quick Ratio [ 19.99 ]
Minimum
Dec 31, 2023
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.12K |
---|---|
min | -0.73 |
max | 5.45 |
average | 1.55 |
median | 1.23 |
std | 1.17 |